In the world of investor relations, Sally Curley is an early adopter of ESG. During her 10-year stint as senior vice president of investor relations at Cardinal Health – between 2008 and 2017 – she co-founded the company’s first cross-functional committee to assess and advance ESG initiatives. In her prior role at Genzyme (now Sanofi) she worked closely with the nomination and governance committee, as the company’s vice president of IR.
After leaving Cardinal Health, Curley set up her own consulting firm, Curley Global IR, which advises clients on investor relations, corporate governance and ESG. In 2019 she won the lifetime achievement award at the IR Magazine Awards – US.
In this video, Curley outlines her view on the role of IR in telling a company’s ESG story and whether ESG information should be discussed on the quarterly earnings call.
This is the sixth episode in our new socially distanced video series, where we profile award winners from around the world. This video was filmed shortly after Tropical Storm Isaia passed Curley’s house, so there is a slight audio lag in a few places. If there’s a particular award winner or award category you would like to see profiled, please email [email protected].
